Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P David Rogers

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|October 18, 2002
Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysisP David Rogers, Katherine S Barker
Current Infectious Disease Reports|October 27, 2006
Recent insights into the mechanisms of antifungal resistanceKatherine S Barker, P David Rogers
Methods in Molecular Medicine|May 13, 2005
Application of deoxyribonucleic acid microarray analysis to the study of azole antifungal resistance in Candida albicansKatherine S Barker, P David Rogers
Current Infectious Disease Reports|October 21, 2016
Azole Resistance in Candida glabrataSarah G Whaley, P David Rogers
Antimicrobial Agents and Chemotherapy|March 26, 2003
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolatesP David Rogers, Katherine S Barker
Antimicrobial Agents and Chemotherapy|September 24, 2008
Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strainsSabrina Schubert, P David Rogers, Joachim Morschhäuser
Virulence|July 27, 2016
Antifungal adjuvants: Preserving and extending the antifungal arsenalArielle Butts, Glen E Palmer, P David Rogers
The Journal of Infectious Diseases|August 10, 2005
Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expressionKatherine S Barker, Teresa Liu, P David Rogers
The Annals of Pharmacotherapy|September 3, 2009
The role of voriconazole in the treatment of central nervous system blastomycosisMai Ta, Stephanie A Flowers, P David Rogers
The Journal of Antimicrobial Chemotherapy|October 12, 2019
Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicansAndrew T Nishimoto, Cheshta Sharma, P David Rogers
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|October 18, 2002
Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysisP David Rogers, Katherine S Barker
Current Infectious Disease Reports|October 27, 2006
Recent insights into the mechanisms of antifungal resistanceKatherine S Barker, P David Rogers
Methods in Molecular Medicine|May 13, 2005
Application of deoxyribonucleic acid microarray analysis to the study of azole antifungal resistance in Candida albicansKatherine S Barker, P David Rogers
Current Infectious Disease Reports|October 21, 2016
Azole Resistance in Candida glabrataSarah G Whaley, P David Rogers
Antimicrobial Agents and Chemotherapy|March 26, 2003
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolatesP David Rogers, Katherine S Barker
Antimicrobial Agents and Chemotherapy|September 24, 2008
Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strainsSabrina Schubert, P David Rogers, Joachim Morschhäuser
Virulence|July 27, 2016
Antifungal adjuvants: Preserving and extending the antifungal arsenalArielle Butts, Glen E Palmer, P David Rogers
The Journal of Infectious Diseases|August 10, 2005
Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expressionKatherine S Barker, Teresa Liu, P David Rogers
The Annals of Pharmacotherapy|September 3, 2009
The role of voriconazole in the treatment of central nervous system blastomycosisMai Ta, Stephanie A Flowers, P David Rogers
The Journal of Antimicrobial Chemotherapy|October 12, 2019
Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicansAndrew T Nishimoto, Cheshta Sharma, P David Rogers
Pageof 11